ストックスクリーナーアプリを入手
162.57
1.54%
2.47
アフターアワーズ：
169.00
6.43
+3.96%
前日終値:
$160.10
開ける：
$160.64
24時間の取引高:
2.52M
Relative Volume:
1.59
時価総額：
$21.98B
収益：
$1.53B
当期純損益:
$-214.69M
株価収益率:
-92.37
EPS:
-1.76
ネットキャッシュフロー:
$-43.68M
1週間 パフォーマンス:
+7.41%
1か月 パフォーマンス:
+22.94%
6か月 パフォーマンス:
+21.22%
1年 パフォーマンス:
+69.95%
1日の値動き範囲:
$158.33
$163.80
1週間の範囲:
$152.32
$163.80
52週間の値動き範囲:
$92.14
$183.00
Natera Inc Stock (NTRA) Company Profile
NTRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
162.57 | 21.98B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
410.78 | 158.51B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
194.82 | 140.78B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
489.98 | 37.91B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
108.70 | 31.23B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.29 | 26.31B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Natera Inc. Reports Strong Q1 2025 Financial Growth - TipRanks
Natera (NTRA) Reports Strong Q1 2025 Growth and Raises Revenue Guidance - GuruFocus
Natera Inc earnings beat by $0.14, revenue topped estimates - Investing.com India
Natera (NTRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Nasdaq
Natera Q1 2025 Earnings Call Transcript - MarketBeat
Natera (NASDAQ:NTRA) Surprises With Strong Q1, Guides for Strong Full-Year Sales - Yahoo Finance
Natera (NTRA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Natera Inc reports results for the quarter ended March 31Earnings Summary - TradingView
NTRA Reports Strong Q1 Revenue Exceeding Expectations | NTRA Stock News - GuruFocus
Natera Q1 2025 slides: 37% revenue growth drives raised guidance - Investing.com
Natera Q1 Net Loss Narrows, Revenue Rises; Increases Full Year Revenue Outlook - marketscreener.com
Natera: Q1 Earnings Snapshot - marketscreener.com
Natera Inc (NTRA) Q1 2025 Earnings: EPS of ($0.50) Beats Estimate, Revenue Surges to $501.8 Million, Exceeding Expectations - GuruFocus
Natera Reports First Quarter 2025 Financial Results - Yahoo Finance
Natera (NTRA) to Present Significant Breast Cancer Data at 2025 ESMO Congress | NTRA Stock News - GuruFocus
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress | NTRA Stock News - GuruFocus
Signatera Data From I-SPY 2 Trial to Be Presented at ESMO Breast Annual Congress - Yahoo Finance
Natera Inc (NTRA) Q1 2025: Everything You Need To Know Ahead Of Earnings - GuruFocus
Cathie Wood’s ARK Makes Bold Tuesday Moves with Key Stock Swaps - Wall Street Pit
Prospera™ Heart Test with DQS Outperforms dd-cfDNA Percentage in Detecting Allograft Rejection, New AJT Publication Shows - Stock Titan
What To Expect From Natera’s (NTRA) Q1 Earnings - Yahoo Finance
Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas - Medical Device Network
Natera (NTRA) Highlights Promising Study Results for Sarcoma Det - GuruFocus
Natera (NTRA) Highlights Promising Study Results for Sarcoma Detection | NTRA Stock News - GuruFocus
Largest Sarcoma Study to Date with ctDNA Analysis Demonstrates Excellent Performance for Signatera | NTRA Stock News - GuruFocus
Breakthrough: Largest-Ever Sarcoma Study Validates Natera's Cancer Detection Test with 93% Accuracy - Stock Titan
Learn to Evaluate (NTRA) using the Charts - news.stocktradersdaily.com
CLASS ACTION: Kessler Topaz Meltzer & Check, LLP Reminds Natera, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses over $250,000 to Contact the Firm - Newsfile
Notice to Shareholders of Natera, Inc. (NTRA) Regarding Dismissal of Putative Investor Class Action - TradingView
Natera to Report its First Quarter Results on May 8, 2025 - BioSpace
Natera’s chief legal officer sells $303,299 in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells shares for $261,449 By Investing.com - Investing.com Canada
Natera president Solomon Moshkevich sells $335,714 in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells shares for $261,449 - Investing.com Australia
Natera co-founder Sheena Jonathan sells $66,808 in stock By Investing.com - Investing.com Canada
Natera co-founder Sheena Jonathan sells $66,808 in stock - Investing.com Australia
Natera’s chief legal officer sells $303,299 in stock - Investing.com
Natera (NasdaqGS:NTRA) Unveils DEFINE-HT Trial Insights in Heart Transplantation Study - Yahoo Finance
Minimal Residual Disease Testing Market Outlook 2024-2031 | Growth Led by Myriad, Natera & Guardant - openPR.com
Revolutionary Prospera Heart Test Shows 3X Better Transplant Monitoring Than Traditional Biopsies - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Prospective DEFINE-HT Study Demonstrates that Prospera™ Heart is Predictive of Clinical Outcomes and Outperforms Biopsy in Predicting Graft Dysfunction - Yahoo Finance
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today - Benzinga
Natera, Inc. Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire
Natera, Inc. (NTRA): One of the Best Aggressive Growth Stocks to Buy Now - Insider Monkey
Natera launches Signatera Genome assay nationwide By Investing.com - Investing.com India
Natera Inc (NTRA) Shares Up 3.01% on Apr 24 - GuruFocus
Natera Announces Broad Clinical Launch of Ultra-Sensitive Signatera™ Genome MRD Test - BioSpace
Natera launches Signatera Genome assay nationwide - Investing.com Australia
Natera, Inc. to Present Data from 8 Studies at 2025 AACR Annual Meeting - marketscreener.com
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
1.58%
0.38%
大文字化:
|
ボリューム (24 時間):